Zucara Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Zucara General Information

Description

Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy is delivered as a subcutaneous injection, which will benefit patients by addressing the significant morbidity and mortality associated with hypoglycemia, enabling healthcare providers to change diabetes disease management and improve patient health.

Contact Information

Website
www.zucara.ca
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1300-661 University Avenue
  • Toronto, Ontario M5G 0B7
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1300-661 University Avenue
  • Toronto, Ontario M5G 0B7
  • Canada

Zucara Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zucara Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 01-Dec-2023 000.00 Completed Clinical Trials - Phase 2
9. Grant 15-Jun-2023 000 000.00 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series A) 31-Mar-2020 0000 000.00 Completed Clinical Trials - Phase 1
7. Grant 12-Jul-2019 0000 00.000 Completed Pre-Clinical Trials
6. Debt - General 09-Apr-2018 00.00 00.000 Completed Pre-Clinical Trials
5. Accelerator/Incubator 09-Feb-2018 00000 Completed Pre-Clinical Trials
4. Grant 08-Feb-2018 00000 00000 Completed Pre-Clinical Trials
3. Grant 21-Sep-2017 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 03-Nov-2016 Cancelled Startup
1. Early Stage VC 03-Nov-2016 $525K $525K Completed Startup
To view Zucara’s complete valuation and funding history, request access »

Zucara Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel drug therapy designed to prevent hypoglycemia in people with diabetes. The company's drug therapy i
Drug Discovery
Toronto, Canada
12 As of 2022
000.00
000000000000 000.00

000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000 000000000
San Diego, CA
000 As of 0000
00000
00000 0000-00-00
000000&0 00000

000000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
0000000000000
Soborg, Denmark
000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zucara Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViaCyte Formerly VC-backed San Diego, CA 000 00000 000000&0 00000
Zealand Pharma Formerly VC-backed Soborg, Denmark 000 00.000 000000000 00.000
Xeris Biopharma Holdings Formerly VC-backed Chicago, IL 000 00000 000000000 00 00000
You’re viewing 3 of 3 competitors. Get the full list »

Zucara Executive Team (7)

Name Title Board Seat
Michael Midmer Co-Founder, Chief Executive Officer & Board Member
Richard Liggins Ph.D Co-Founder & Chief Scientific Officer
Michael Riddell Ph.D Co-Founder & Chairman, Clinical/ Scientific Advisory Board
David Coy Ph.D Academic Co-Founder
Claude Piché Chairman
You’re viewing 5 of 7 executive team members. Get the full list »

Zucara Board Members (7)

Name Representing Role Since
Christopher Garabedian Self Board Member 000 0000
Claude Piché Self Chairman 000 0000
Frederick Callori JD Xontogeny Board Member 000 0000
Michael Martin Self Board Member 000 0000
Michael Midmer Zucara Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Zucara Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zucara Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Toronto Entrepreneurship Accelerator/Incubator 000 0000 000000 0
Juvenile Diabetes Research Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
Xontogeny Accelerator/Incubator Minority 000 0000 000000 0
GlycoNet Not-For-Profit Venture Capital 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Zucara FAQs

  • When was Zucara founded?

    Zucara was founded in 2014.

  • Who is the founder of Zucara?

    Michael Midmer, Richard Liggins Ph.D, Michael Riddell Ph.D, David Coy Ph.D, and Mladen Vranic Ph.D are the founders of Zucara.

  • Who is the CEO of Zucara?

    Michael Midmer is the CEO of Zucara.

  • Where is Zucara headquartered?

    Zucara is headquartered in Toronto, Canada.

  • What is the size of Zucara?

    Zucara has 12 total employees.

  • What industry is Zucara in?

    Zucara’s primary industry is Drug Discovery.

  • Is Zucara a private or public company?

    Zucara is a Private company.

  • What is Zucara’s current revenue?

    The current revenue for Zucara is 00000.

  • How much funding has Zucara raised over time?

    Zucara has raised $25.4M.

  • Who are Zucara’s investors?

    University of Toronto Entrepreneurship, Juvenile Diabetes Research Foundation, Perceptive Advisors, Xontogeny, and GlycoNet are 5 of 10 investors who have invested in Zucara.

  • Who are Zucara’s competitors?

    ViaCyte, Zealand Pharma, and Xeris Biopharma Holdings are competitors of Zucara.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »